JNJ Today - Aug 08: Insider Selling Hits Stock

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

JNJ Today - Aug 08: Insider Selling Hits Stock

無料で聴く

ポッドキャストの詳細を見る

Hey there! It's Joey here, your friendly neighborhood investor, breaking down what went down today with Johnson & Johnson. So, JNJ had a bit of a green day, up almost one percent. Not a huge leap, but hey, green's green, right?

Now, let’s talk about what happened. The stock was buzzing around the same price range most of the day, barely moving until the close. It finished up just a little, which is nice, but there’s definitely a bit of a mixed vibe in the air.

So, what's the scoop behind the scenes? Well, there’s been some insider selling going on that's got folks raising an eyebrow. The CEO of J&J, Joaquín Duato, sold a whopping $12.5 million worth of his shares. Yeah, that one stung a bit for investors. When the big boss sells off that much stock, it can make people a little jittery. Plus, Rockland Trust Co. sold over 20,000 shares too. That’s a pretty big chunk, so it’s not just one person bailing out.

On top of that, there’s chatter about whether J&J is fully valued right now, especially with their Darzalex royalties. Some analysts are scratching their heads, wondering if the stock is being priced just right. It’s like when you find a shirt on sale, but you’re not sure if it’s a steal or if it’s just overpriced clearance.

One quick thing worth knowing: J&J's got some big plans on the horizon with their pharmaceutical pipeline. They’re working on new treatments that could really shake things up. That’s something to keep an eye on as we see how it all unfolds.

Alright, that’s a wrap for today’s JNJ breakdown! Just remember, this is all about sharing info and having fun with the stock market—no financial advice here. Catch you later!

まだレビューはありません